Topical imiquimod

DRUG3 trials

Sponsors

Medical University of Vienna, Washington University School of Medicine, Instituto Oncológico Dr Rosell

Conditions

Cervical Intraepithelial NeoplasiaCutaneous Basal Cell CarcinomaMetastatic Breast Cancer

Phase 1

Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer

TerminatedNCT03982004

Washington University School of MedicineMetastatic Breast Cancer

Start: 2020-09-14End: 2021-03-03Updated: 2021-06-21

Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma

RecruitingNCT07251413

Instituto Oncológico Dr RosellCutaneous Basal Cell Carcinoma

Start: 2025-10-22End: 2028-12-31Target: 18Updated: 2025-12-01

Phase 3

Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia

TerminatedNCT01283763

Medical University of ViennaCervical Intraepithelial Neoplasia

Start: 2013-05-31End: 2018-01-31Updated: 2016-11-01

Related Papers

Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial

Gynecologic Oncology2022-02-1429 citations